openPR Logo
Press release

Oncolytic Virus Therapy Market Size, Latest Rising Trend & Forecast to 2027 - Lead by Amgen, Transgene, Oncolys BioPharma, Vyriad, Genelux and Lokon Pharma AB

10-07-2020 03:25 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
Oncolytic Virus Therapy Market

Oncolytic Virus Therapy Market

The report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

An oncolytic virus is a unique virus that favorably infects and kills cancer cells. These are deployed as a part of cancer immunotherapy and act by selectively targeting cancer cells and carrying out oncolysis. The oncolytic virus is known to kill the cancer cells directly and stimulate the patient's own anti-tumor immune responses. The first oncolytic virus immunotherapy was approved in Latvia in 2004 for the treatment of skin melanoma. Inevitable changes in the environment occurring due to human activity are giving rise to various factors leading to an increase in the incidence of numerous cutaneous malignancies, including non-melanoma skin cancer.

The conventional radiation and chemotherapy for the treatment of various cancers, including skin melanomas, have a restricted therapeutic index and an array of therapy related side effects. The first US FDA approved oncolytic herpes virus (a modified herpes simplex virus) is the drug talimogene laherparepvec (OncoVex, T-VEC), approved in 2015 for the treatment of advanced inoperable melanoma.

Download a Sample Report Explore further @ https://bit.ly/2SwvfV4

The increasing incidence rate of cancers and rise in adoption of advanced treatment options will spur the demand of the oncolytic virus market. However, treatment-related off-target effects, side effects, and drug resistance may restraint the growth of the market in the forecasted period. Additionally, huge investment in research and development and rising geriatric population and changing lifestyle in developing economies will boost the growth of the market in the forecasted period.

Top Dominating Key Players:

1. Amgen Inc
2. Oncolytics Biotech, Inc.
3. Merck & Co., Inc.
4. Transgene
5. Oncolys BioPharma Inc.
6. Targovax ASA
7. Vyriad Inc.
8. Genelux Corporation
9. Sorrento Therapeutics, Inc.
10. Lokon Pharma AB

Market Segmentation :

The global oncolytic virus market is segmented on the product type, application and end-users. Based on product type, the global oncolytic virus market is segmented into HSV-based oncolytic viruses, Adenoviruses-based oncolytic viruses, Vaccinia virus-based oncolytic viruses, Vesicular Stomatitis virus-based oncolytic viruses, and Newcastle disease virus-based oncolytic viruses. Based on application, the global oncolytic virus market is segmented into breast cancer, lung cancer, prostate cancer, melanoma, brain tumor, blood cancer, and others. Based on the end-users, the oncolytic virus market is segmented hospitals, specialty clinics, and cancer research institutes.

Key questions answered in the report include

What will the market size and the growth rate be in 2027?
What are the key factors driving the global Oncolytic Virus Therapy market?
What are the key market trends impacting the growth of the Oncolytic Virus Therapy market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the vendors in the global Oncolytic Virus Therapy market?
Trending factors influencing the market shares of the Americas, APAC, and EMEA?
What are the key outcomes of the five forces analysis of the Oncolytic Virus Therapy market?

The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Oncolytic Virus Therapy Market. Further, the report conducts an intricate examination of drivers and restraints operating in the market. The report also evaluates the trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal according to different segments. The report also predicts the influence of different industry aspects on the Oncolytic Virus Therapy Market segments and regions.

Scope of the study:

The research on the Oncolytic Virus Therapy Market focuses on mining out valuable data on investment pockets, growth opportunities, and major market vendors to help clients understand their competitor’s methodologies. The research also segments the Oncolytic Virus Therapy Market on the basis of end user, product type, application, and demography for the forecast period 2020 - 2027. Comprehensive analysis of critical aspects such as impacting factors and competitive landscape are showcased with the help of vital resources, such as charts, tables, and infographics.

Request for Buy Report @ https://bit.ly/2SBHTSF

Reasons to Buy the Report:

Learn about the driving factors, affecting the market growth.
Imbibe the advancements and progress in the market during the forecast period.
Understand where the market opportunities lies.
Compare and evaluate various options affecting the market.
Pick up on the leading market players within the market.
Envision the restrictions and restrains that are likely to hamper the market.

Contact Us:

The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncolytic Virus Therapy Market Size, Latest Rising Trend & Forecast to 2027 - Lead by Amgen, Transgene, Oncolys BioPharma, Vyriad, Genelux and Lokon Pharma AB here

News-ID: 2151516 • Views:

More Releases from The Insight Partners

Insect Pest Control - Obtain PDF Sample Copy
The Insect Pest Control Market size is projected to reach US$ 14.85 billion by 2031 from US$ 21.33 billion in 2024. The market is expected to register a CAGR of 5.4% during 2025-2031. The proactive health measures, combined with heightened consumer awareness about disease prevention, have boosted the demand for both professional pest control services and DIY products. The convergence of public health policies, regulatory vigilance, and increased risk perception
Denim Fabrics - Obtain PDF Sample Copy
The denim fabrics market size is projected to reach US$ 28.69 billion by 2031 from US$ 22.32 billion in 2024. The market is expected to register a CAGR of 3.8% during 2025-2031. The denim fabrics market is growing steadily owing to changing consumer preferences, fashion trends, and increasing accessibility. Denim has evolved from being a utilitarian fabric to a mainstream fashion item, appreciated for its flexibility, comfort, and ease. With
Photomedicine Devices and Technologies Market Global Rising Demand & Huge Scope Till 2028
Photomedicine Devices and Technologies Market Global Rising Demand & Huge Scope …
A new market study report by The Insight Partners on the Photomedicine Devices and Technologies Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. Get PDF Sample
Genetic Testing Services Market Global Rising Demand & Huge Scope Till 2031
Genetic Testing Services Market Global Rising Demand & Huge Scope Till 2031
Genetic Testing Services Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market

All 5 Releases


More Releases for Oncolytic

Prominent Oncolytic Virus Therapy Market Trend for 2025: Accelerating Oncolytic …
Which drivers are expected to have the greatest impact on the over the oncolytic virus therapy market's growth? The rise in cancer incidences is likely to fuel the expansion of the oncolytic virus therapy market. Oncolytic virus therapy is gaining traction as an appealing approach to treating cancer- a collection of diseases marked by abnormal cell growth and proliferation. This therapeutic strategy effectively targets and eliminates cancer cells, while also triggering
Enhancing the Immune Response with Oncolytic Virus Therapy
Oncolytic virus therapy is revolutionizing cancer treatment by harnessing the unique characteristics of viruses to specifically target and destroy cancer cells. This cutting-edge approach represents a significant advancement in cancer care, offering renewed hope for patients with different types of cancer. Download Report: https://www.kuickresearch.com/report-oncolytic-virus-immunotherapy-market-oncolytic-virus-therapy-market-oncolytic-virus-fda-approved-oncolytic-virus-clinical-trilas The essence of oncolytic virus therapy is based on genetically modified viruses that can selectively attack and kill cancer cells while leaving healthy tissue unharmed. These engineered viruses take
Creative Biolabs Unleashes Solutions to Validate Oncolytic Virotherapy
Creative Biolabs introduces safety and efficacy validation strategies for oncolytic virotherapy. New York, USA - June 17, 2024 - Oncolytic virotherapy appears as a new paradigm in cancer immunotherapy that enrolls specifically engineered viruses to selectively infect and kill cancer cells, some of which have marched into clinical trials, like adenoviruses, HSV, reovirus, vaccinia virus, and measles. With so many other candidates still on their preclinical journey, the requests to validate
Oncolytic Virus Competitive Landscape 2023 (Updated)
DelveInsight's, "Oncolytic Virus Competitive Landscape 2023" report provides comprehensive insights about 150+ Oncolytic Virus Companies and 175+ drugs in the Oncolytic Virus Competitive landscape. It covers the Oncolytic Virus therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Oncolytic Virus Competitive Landscape Report • DelveInsight's Oncolytic Virus report depicts a robust space with 150+ Oncolytic
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Oncolytic Virus 1.1 Outline of Oncolytic Virotherapy 1.2 Trail from Genesis to Biogenetics Primer of Virotherapy in Malignancies 2.1 Oncolytic Viruses towards Cancer 2.2 Approaches for Targeting Tumor Cells 2.2.1 Pro Apoptotic Targeting 2.2.2 Translational Targeting 2.2.3 Transcriptional Targeting 2.2.4 Transductional Targeting Mechanism
Global Oncolytic Virus Therapy Report Highlight Market Opportunity & Insight On …
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic